Scarica l'app Stockscreener
113.76
1.74%
1.95
Dopo l'orario di chiusura:
113.76
Precedente Chiudi:
$111.81
Aprire:
$110.77
Volume 24 ore:
833.23K
Relative Volume:
1.40
Capitalizzazione di mercato:
$7.56B
Reddito:
$136.86M
Utile/perdita netta:
$-168.69M
Rapporto P/E:
-40.48
EPS:
-2.81
Flusso di cassa netto:
$-113.49M
1 W Prestazione:
+2.98%
1M Prestazione:
+12.64%
6M Prestazione:
+74.51%
1 anno Prestazione:
+138.34%
Intervallo 1D:
$108.56
$114.39
Intervallo di 1 settimana:
$108.56
$116.00
Portata 52W:
$45.91
$116.00
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Nome
Rhythm Pharmaceuticals Inc
Settore
Industria
Telefono
857-264-4280
Indirizzo
222 BERKELEY STREET, BOSTON, MA
Confronta RYTM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
113.76 | 7.43B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-07-07 | Iniziato | Leerink Partners | Outperform |
| 2025-04-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2025-01-02 | Iniziato | Jefferies | Buy |
| 2024-12-20 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Guggenheim | Buy |
| 2024-09-18 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-01-18 | Ripresa | Canaccord Genuity | Buy |
| 2022-08-08 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-05 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Reiterato | Needham | Buy |
| 2022-03-02 | Ripresa | Stifel | Buy |
| 2022-02-17 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Iniziato | Wells Fargo | Overweight |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Ripresa | Goldman | Neutral |
| 2021-08-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-08 | Iniziato | Goldman | Sell |
| 2019-07-12 | Aggiornamento | Stifel | Hold → Buy |
| 2019-07-08 | Iniziato | Canaccord Genuity | Buy |
| 2019-03-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-09-07 | Ripresa | Morgan Stanley | Overweight |
| 2018-06-25 | Reiterato | Needham | Buy |
| 2018-06-15 | Reiterato | Needham | Buy |
| 2017-10-30 | Iniziato | BofA/Merrill | Buy |
| 2017-10-30 | Iniziato | Needham | Buy |
Mostra tutto
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
Is Rhythm Pharmaceuticals Inc. stock positioned for digital transformationGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Rhythm Pharmaceuticals Hits New 52-Week High of $116.00 - Markets Mojo
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Can machine learning forecast Rhythm Pharmaceuticals Inc. recoveryJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Can Rhythm Pharmaceuticals Inc. (1RV) stock hold up in economic slowdownJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
Visualizing Rhythm Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
How currency fluctuations impact Rhythm Pharmaceuticals Inc. stock2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Will Rhythm Pharmaceuticals Inc. stock benefit from automation2025 Dividend Review & Community Driven Trade Alerts - newser.com
How resilient is Rhythm Pharmaceuticals Inc. stock in market downturns2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Is it time to cut losses on Rhythm Pharmaceuticals Inc.2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Will Rhythm Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells $323,753.15 in Stock - MarketBeat
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowMarket Trend Review & Accurate Trade Setup Notifications - newser.com
Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. reversing from oversold territoryQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Investors Are Less Pessimistic Than Expected - 富途牛牛
Rhythm Pharmaceuticals (NASDAQ:RYTM) Sets New 1-Year HighHere's What Happened - MarketBeat
Rhythm Pharmaceuticals (RYTM) to Release Earnings on Tuesday - MarketBeat
Rhythm Pharmaceuticals stock reaches all-time high at 114.04 USD By Investing.com - Investing.com Australia
Three Boston biotechs await FDA decisions on new drugs by year-end - The Business Journals
Published on: 2025-10-29 02:54:50 - newser.com
Rhythm Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Rhythm Pharmaceuticals stock reaches all-time high at 114.04 USD - Investing.com
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Why Rhythm Pharmaceuticals Inc. stock is in analyst buy zone2025 Price Targets & Smart Allocation Stock Reports - newser.com
Risk Hedge: Is Rhythm Pharmaceuticals Inc. stock a top momentum playTake Profit & Real-Time Buy Signal Notifications - Fundação Cultural do Pará
Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):